{"event":"adhd-medication-shortage-and-telehealth-tracker","title":"ADHD medication shortage and telehealth tracker (to 11 Oct 2026)","state":"developing","updated":"2026-10-11T00:00:00.000Z","entries":[{"id":"cicuay","at":"2026-10-09T00:00:00.000Z","title":"Stimulant shortages still listed as current by FDA","status":"confirmed","cites":[{"id":"mh-adhd-shortage-amphetamine-availability","n":9,"url":"https://api.fda.gov/drug/shortages.json?search=generic_name:amphetamine&limit=1000","publisher":"US Food and Drug Administration (openFDA drug shortages)","short":"US Food and Drug…"},{"id":"mh-adhd-shortage-lisdexamfetamine","n":2,"url":"https://api.fda.gov/drug/shortages.json?search=generic_name:lisdexamfetamine&limit=1000","publisher":"US Food and Drug Administration (openFDA drug shortages)","short":"US Food and Drug…"},{"id":"mh-adhd-shortage-methylphenidate","n":3,"url":"https://api.fda.gov/drug/shortages.json?search=generic_name:methylphenidate&limit=1000","publisher":"US Food and Drug Administration (openFDA drug shortages)","short":"US Food and Drug…"}]},{"id":"gji0kx","at":"2026-07-07T00:00:00.000Z","title":"Done Global founder sentenced to six years","status":"confirmed","body":"A jury had convicted founder Ruthia He and clinical president David Brody in November 2025; Brody was sentenced to two years.","cites":[{"id":"mh-adhd-done-sentence","n":8,"url":"https://www.justice.gov/opa/pr/founderceo-and-clinical-president-digital-health-company-sentenced-8-years-90-million-scheme","publisher":"US Department of Justice, Office of Public Affairs","short":"US Department of Justice"},{"id":"mh-adhd-done-conviction","n":21,"url":"https://www.justice.gov/opa/pr/founderceo-and-clinical-president-digital-health-company-sentenced-8-years-90-million-scheme","publisher":"US Department of Justice, Office of Public Affairs","short":"US Department of Justice"},{"id":"mh-adhd-done-scheme","n":22,"url":"https://www.justice.gov/opa/pr/founderceo-and-clinical-president-digital-health-company-sentenced-8-years-90-million-scheme","publisher":"US Department of Justice, Office of Public Affairs","short":"US Department of Justice"}]},{"id":"e0af9v","at":"2026-01-05T00:00:00.000Z","title":"DEA sets 2026 production quotas after 5,044 comments","status":"confirmed","cites":[{"id":"mh-adhd-dea-2026-apq","n":6,"url":"https://www.federalregister.gov/documents/2026/01/05/2025-24277/established-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment","publisher":"Drug Enforcement Administration (Federal Register)","short":"Drug Enforcement…"},{"id":"mh-adhd-dea-2026-comments","n":14,"url":"https://www.federalregister.gov/documents/2026/01/05/2025-24277/established-aggregate-production-quotas-for-schedule-i-and-ii-controlled-substances-and-assessment","publisher":"Drug Enforcement Administration (Federal Register)","short":"Drug Enforcement…"}]},{"id":"f5d8h","at":"2025-12-31T00:00:00.000Z","title":"Fourth extension of telemedicine flexibilities, through 2026","status":"confirmed","cites":[{"id":"mh-adhd-telemedicine-fourth-extension","n":7,"url":"https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled","publisher":"Drug Enforcement Administration and HHS (Federal Register)","short":"Drug Enforcement…"}]},{"id":"1a0xikw","at":"2025-10-02T00:00:00.000Z","title":"DEA raises 2025 d-amphetamine and methylphenidate quotas","status":"confirmed","cites":[{"id":"mh-adhd-dea-damph-mph-2025","n":5,"url":"https://www.federalregister.gov/documents/2025/10/02/2025-19335/adjustment-to-the-aggregate-production-quota-for-d-amphetamine-for-sale-and-methylphenidate-for-sale","publisher":"Drug Enforcement Administration (Federal Register)","short":"Drug Enforcement…"}]},{"id":"rmhviy","at":"2025-09-19T00:00:00.000Z","title":"DEA raises 2025 lisdexamfetamine quota by about 22%","status":"confirmed","cites":[{"id":"mh-adhd-dea-lisdex-2025","n":4,"url":"https://www.federalregister.gov/documents/2025/09/19/2025-18110/adjustment-to-the-aggregate-production-quota-for-lisdexamfetamine-and-d-amphetamine-for-conversion","publisher":"Drug Enforcement Administration (Federal Register)","short":"Drug Enforcement…"},{"id":"mh-adhd-dea-lisdex-reason","n":13,"url":"https://www.federalregister.gov/documents/2025/09/19/2025-18110/adjustment-to-the-aggregate-production-quota-for-lisdexamfetamine-and-d-amphetamine-for-conversion","publisher":"Drug Enforcement Administration (Federal Register)","short":"Drug Enforcement…"}]},{"id":"1uukrio","at":"2025-09-09T00:00:00.000Z","title":"MAHA strategy announces HHS working group on children's prescriptions","status":"confirmed","cites":[{"id":"mh-adhd-maha-strategy-working-group","n":30,"url":"https://www.whitehouse.gov/wp-content/uploads/2025/09/The-MAHA-Strategy-WH.pdf","publisher":"The White House, Make America Healthy Again Commission","short":"The White House"}]},{"id":"1dob0k1","at":"2025-08-13T00:00:00.000Z","title":"BMJ register study links ADHD medicine to fewer harmful outcomes","status":"confirmed","body":"Observational target-trial emulation in 148,581 people in Sweden.","cites":[{"id":"mh-adhd-zhang-2025-outcomes","n":34,"url":"https://pubmed.ncbi.nlm.nih.gov/40803836/","publisher":"The BMJ (PubMed record)","short":"The BMJ"}]},{"id":"1ygbtho","at":"2025-05-29T00:00:00.000Z","title":"Reporters find non-existent ADHD studies cited in MAHA report","status":"confirmed","body":"The White House called the errors formatting issues; the references were later removed.","cites":[{"id":"mh-adhd-maha-fake-citations","n":28,"url":"https://www.notus.org/health-science/make-america-healthy-again-report-citation-errors","publisher":"NOTUS","short":"NOTUS"},{"id":"mh-adhd-maha-citations-response","n":29,"url":"https://www.cidrap.umn.edu/public-health/maha-report-chronic-disease-us-kids-includes-fake-citations-other-errors","publisher":"CIDRAP (University of Minnesota)","short":"CIDRAP"}]},{"id":"ovgj6i","at":"2025-05-22T00:00:00.000Z","title":"MAHA Commission report questions stimulant use in children","status":"confirmed","cites":[{"id":"mh-adhd-maha-stimulant-claims","n":26,"url":"https://www.whitehouse.gov/wp-content/uploads/2025/05/WH-The-MAHA-Report-Assessment.pdf","publisher":"The White House, Make America Healthy Again Commission","short":"The White House"},{"id":"mh-adhd-maha-withdrawal-claim","n":27,"url":"https://www.whitehouse.gov/wp-content/uploads/2025/05/WH-The-MAHA-Report-Assessment.pdf","publisher":"The White House, Make America Healthy Again Commission","short":"The White House"}]},{"id":"10cx8ot","at":"2025-01-17T00:00:00.000Z","title":"DEA proposes special registration for telemedicine","status":"confirmed","cites":[{"id":"mh-adhd-special-registration-proposed","n":19,"url":"https://www.federalregister.gov/documents/2025/01/17/2025-01099/special-registrations-for-telemedicine-and-limited-state-telemedicine-registrations","publisher":"Drug Enforcement Administration (Federal Register)","short":"Drug Enforcement…"}]},{"id":"16q4rzp","at":"2024-11-19T00:00:00.000Z","title":"Third extension of telemedicine flexibilities, to end of 2025","status":"confirmed","cites":[{"id":"mh-adhd-telemedicine-third-extension","n":18,"url":"https://www.federalregister.gov/documents/2024/11/19/2024-27018/third-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled","publisher":"Drug Enforcement Administration and HHS (Federal Register)","short":"Drug Enforcement…"}]},{"id":"7lxxzy","at":"2024-11-04T00:00:00.000Z","title":"Cerebral signs non-prosecution agreement over ADHD stimulant prescribing","status":"confirmed","body":"The telehealth company agreed to forfeit $3.65 million, with a $2.92 million fine deferred.","cites":[{"id":"mh-adhd-cerebral-npa","n":24,"url":"https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions","publisher":"TechTarget (Virtual Healthcare)","short":"TechTarget"},{"id":"mh-adhd-cerebral-conduct","n":25,"url":"https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions","publisher":"TechTarget (Virtual Healthcare)","short":"TechTarget"}]},{"id":"19wnfwy","at":"2024-10-10T00:00:00.000Z","title":"CDC publishes first national data on adult ADHD diagnosis and telehealth","status":"confirmed","body":"15.5 million adults had a current diagnosis in 2023; 71.5% of those taking stimulants had trouble filling prescriptions.","cites":[{"id":"mh-adhd-cdc-adults-prevalence","n":33,"url":"https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"},{"id":"mh-adhd-cdc-adults-stimulant-shortage","n":11,"url":"https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"},{"id":"mh-adhd-cdc-adults-telehealth","n":20,"url":"https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"}]},{"id":"1iycc1t","at":"2023-07-26T00:00:00.000Z","title":"Extended-release methylphenidate shortage posted","status":"confirmed","cites":[{"id":"mh-adhd-shortage-methylphenidate","n":3,"url":"https://api.fda.gov/drug/shortages.json?search=generic_name:methylphenidate&limit=1000","publisher":"US Food and Drug Administration (openFDA drug shortages)","short":"US Food and Drug…"}]},{"id":"1lf3j3u","at":"2023-07-14T00:00:00.000Z","title":"Lisdexamfetamine shortage posted","status":"confirmed","cites":[{"id":"mh-adhd-shortage-lisdexamfetamine","n":2,"url":"https://api.fda.gov/drug/shortages.json?search=generic_name:lisdexamfetamine&limit=1000","publisher":"US Food and Drug Administration (openFDA drug shortages)","short":"US Food and Drug…"}]},{"id":"pw11r4","at":"2023-03-31T00:00:00.000Z","title":"CDC reports a rise in stimulant prescription fills, especially among adults","status":"confirmed","body":"The share of commercially insured people filling a stimulant prescription rose from 3.6% in 2016 to 4.1% in 2021.","cites":[{"id":"mh-adhd-mmwr-fills-trend","n":31,"url":"https://www.cdc.gov/mmwr/volumes/72/wr/mm7213a1.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"},{"id":"mh-adhd-mmwr-fills-adults","n":32,"url":"https://www.cdc.gov/mmwr/volumes/72/wr/mm7213a1.htm","publisher":"US Centers for Disease Control and Prevention (MMWR)","short":"US Centers for Disease…"}]},{"id":"1mrphos","at":"2022-10-12T00:00:00.000Z","title":"FDA lists immediate-release Adderall and generics in shortage","status":"confirmed","cites":[{"id":"mh-adhd-shortage-amphetamine","n":1,"url":"https://api.fda.gov/drug/shortages.json?search=generic_name:amphetamine&limit=1000","publisher":"US Food and Drug Administration (openFDA drug shortages)","short":"US Food and Drug…"}]}]}